Recombinant Salmonella paratyphi B Bifunctional protein aas (aas)

Basic Research Questions

• What is Recombinant Salmonella paratyphi B Bifunctional protein aas (aas) and what are its key characteristics?

  Recombinant Salmonella paratyphi B Bifunctional protein aas is a full-length protein (amino acids 1-719) derived from Salmonella paratyphi B, corresponding to UniProt accession number A9N3H8. It is typically produced as a recombinant protein with an N-terminal His-tag for purification purposes and expressed in E. coli expression systems . The "bifunctional" designation indicates dual enzymatic or structural roles, which is common among bacterial metabolic proteins. The recombinant form maintains the complete amino acid sequence of the native protein while adding the His-tag to facilitate isolation through immobilized metal affinity chromatography.

  Table 1: Key Characteristics of Recombinant Salmonella paratyphi B Bifunctional protein aas

  Characteristic	Description
  Protein Length	Full Length (1-719 amino acids)
  Expression System	E. coli
  Tag	N-terminal His-tag
  Form	Lyophilized powder
  Purity	>90% (SDS-PAGE verified)
  Molecular Mass	Approximately 78-80 kDa (estimated)

• What are the optimal storage and handling conditions for Recombinant Salmonella paratyphi B Bifunctional protein aas?

  Proper storage and handling are critical for maintaining protein stability and activity. The recommended protocols for Recombinant Salmonella paratyphi B Bifunctional protein aas are :

  Table 2: Storage and Handling Guidelines

  Parameter	Recommendation
  Long-term storage	-20°C to -80°C
  Working aliquots	4°C for up to one week
  Storage buffer	Tris/PBS-based buffer, 6% Trehalose, pH 8.0
  Reconstitution	Deionized sterile water to 0.1-1.0 mg/mL
  Stabilization	Add glycerol to 5-50% final concentration for freezing
  Important precautions	Avoid repeated freeze-thaw cycles; centrifuge vial before opening

  The methodological approach to reconstitution should include:

  1. Brief centrifugation of the vial before opening

  2. Addition of deionized sterile water to the recommended concentration

  3. Gentle mixing until completely dissolved

  4. Addition of glycerol for preparations intended for long-term storage

  5. Division into small single-use aliquots to prevent freeze-thaw degradation

• How does Salmonella paratyphi B relate to other Salmonella strains in phylogenetic and virulence contexts?

  Salmonella paratyphi B belongs to Salmonella enterica subspecies enterica, the group responsible for most human Salmonella infections. Within the Salmonella taxonomy, paratyphi B represents a complex serotype with distinct clinical and genetic characteristics :

  Table 3: Comparative Analysis of Salmonella paratyphi B Lineages

  Lineage	d-Tartrate Fermentation	Major Clinical Presentation	Geographic Distribution	Key Genetic Features
  O:5 antigen positive	Variable	Mixed (gastroenteritis and invasive)	Widespread	Additional fimbrial and virulence genes, may contain SGI-1
  O:5 antigen negative	Positive (dT+)	Primarily gastroenteritis	Belgium, Netherlands, Germany (poultry)	Multidrug resistant, fewer virulence determinants
  Phylogenetic Group 1 (PG1)	Negative (dT-)	Strong association with invasive disease	Historical lineage	Specific virulence repertoire

  Methodologically, researchers distinguish these lineages through:

  1. Serotyping based on lipopolysaccharide (O) and flagellar (H) antigens

  2. PCR-based detection of the O:5 antigen-encoding oafA gene

  3. d-Tartrate fermentation assays

  4. Whole genome sequencing with SNP-based phylogenetic analysis

  5. Virulence gene profiling using specific genetic markers

• What genotyping tools are available for Salmonella paratyphi research and how are they applied?

  Several genotyping frameworks have been developed to characterize Salmonella paratyphi strains:

  1. Paratype: A single nucleotide polymorphism (SNP) based genotyping scheme specifically developed for Salmonella Paratyphi A, categorizing strains into three primary clades, nine secondary clades, and 18 genotypes . Each genotype has a unique allele definition located on a conserved gene.

  2. Multi-Locus Sequence Typing (MLST): Used for broader Salmonella classification, including paratyphi B variants.

  3. Whole Genome Sequencing (WGS) approaches that identify:

     • Antimicrobial resistance markers

     • O-polysaccharide synthesis locus mutations

     • Phylogenetic groups based on core genome SNPs

  Methodologically, researchers can implement these tools through:

  1. DNA extraction from pure bacterial cultures

  2. PCR amplification of target loci or whole genome sequencing

  3. Bioinformatic analysis using specialized software like Paratype (available at https://github.com/CHRF-Genomics/Paratype)

  4. Phylogenetic tree construction based on SNP patterns

  5. Integration with antimicrobial resistance and virulence profiling data

Advanced Research Questions

• What are the predicted functional domains of Salmonella paratyphi B Bifunctional protein aas and how can they be experimentally verified?

  Based on sequence analysis of the 719-amino acid protein, several putative functional domains can be predicted:

  Table 4: Predicted Functional Domains and Verification Methods

  Domain	Approximate Position	Predicted Function	Experimental Verification Method
  N-terminal domain	aa 1-250	Membrane interaction, substrate recognition	Site-directed mutagenesis, liposome binding assays
  Central catalytic domain	aa 251-500	ATP binding, enzymatic activity	ATP binding assays, activity measurements with domain-specific substrates
  C-terminal domain	aa 501-719	Secondary catalytic function, protein-protein interaction	Co-immunoprecipitation, truncation analysis
  ATP-binding motif	aa ~450-470	"FTSGSEGHPKG" region suggesting ATP binding	Fluorescence-based ATP binding assays, mutation of key residues

  Methodological approaches for domain verification include:

  1. Expression of individual domains as soluble proteins

  2. Domain-specific activity assays to assess function

  3. Circular dichroism to confirm proper folding

  4. Limited proteolysis to identify domain boundaries

  5. X-ray crystallography or NMR studies of individual domains

  6. Cross-linking studies to identify interaction partners of specific domains

• How can researchers optimize expression and purification protocols for Recombinant Salmonella paratyphi B Bifunctional protein aas?

  Optimization of expression and purification requires systematic testing of multiple conditions:

  Table 5: Expression and Purification Optimization Parameters

  Parameter	Variables to Test	Evaluation Method
  E. coli strain	BL21(DE3), Rosetta, Arctic Express, SHuffle	SDS-PAGE, Western blot for yield and solubility
  Culture medium	LB, TB, 2xYT, M9, Autoinduction	Growth curves, final OD600, protein yield
  Induction conditions	IPTG concentration (0.1-1.0 mM), temperature (16-37°C), duration (3-24h)	SDS-PAGE for optimal expression level
  Cell lysis	Sonication, French press, chemical lysis, enzymatic lysis	Total protein recovery, activity preservation
  Purification strategy	IMAC resins (Ni-NTA, Co-TALON), buffer conditions, imidazole gradient	Purity by SDS-PAGE, yield quantification
  Tag removal	TEV protease, Factor Xa, Thrombin	Cleavage efficiency, activity comparison

  Methodological considerations should include:

  1. Small-scale expression tests before scaling up

  2. Inclusion of protease inhibitors during purification

  3. Protein folding verification through circular dichroism or fluorescence assays

  4. Activity assays at each purification step to track specific activity

  5. Stability testing of the purified protein under various buffer conditions

• What are the challenges and solutions in crystallizing Recombinant Salmonella paratyphi B Bifunctional protein aas for structural studies?

  Crystallizing large, multi-domain proteins like the 719-amino acid Bifunctional protein aas presents several challenges:

  Table 6: Crystallization Challenges and Methodological Solutions

  Challenge	Description	Methodological Solution
  Size and flexibility	Large proteins with multiple domains often have flexible linkers	Express individual domains separately; use limited proteolysis to identify stable fragments
  Protein homogeneity	Heterogeneous post-translational modifications or degradation	Size exclusion chromatography as final purification step; mass spectrometry verification
  Buffer optimization	Standard storage buffers may not be ideal for crystallization	Systematic buffer screening with commercial crystallization kits; thermal shift assays for buffer stability
  His-tag interference	N-terminal tag may prevent crystal contacts	Compare crystallization with and without the tag; create constructs with cleavable tags
  Dynamic conformations	Multiple conformational states prevent lattice formation	Co-crystallization with substrates, inhibitors, or binding partners to stabilize conformation

  Alternative structural biology approaches when crystallization proves challenging:

  1. Cryo-electron microscopy for large proteins or complexes

  2. Small angle X-ray scattering (SAXS) for low-resolution envelope determination

  3. Nuclear magnetic resonance (NMR) for structural studies of domains <25 kDa

  4. Hydrogen-deuterium exchange mass spectrometry for dynamics and domain organization

  5. Integrative structural biology combining multiple experimental approaches

• How can Recombinant Salmonella paratyphi B Bifunctional protein aas be utilized in developing novel antimicrobial strategies?

  The bifunctional nature of the aas protein may present unique opportunities for antimicrobial development:

  Table 7: Antimicrobial Development Strategies Targeting aas

  Approach	Rationale	Methodological Implementation
  Inhibitor screening	Disruption of aas function may impair bacterial survival	High-throughput screening of chemical libraries against purified aas protein activity
  Structure-based drug design	Knowledge of active site architecture enables rational design	Molecular docking of virtual compounds into predicted active sites
  Peptide mimetics	Designing peptides that interfere with protein-protein interactions	Phage display to identify peptides that bind to aas interaction interfaces
  Combination approaches	Synergistic effects with existing antibiotics	Checkerboard assays to identify synergistic combinations of aas inhibitors with antibiotics
  Vaccine development	aas as a potential antigenic target	Immunogenicity testing of recombinant aas in animal models

  Methodological considerations for evaluating potential antimicrobials:

  1. Development of robust activity assays for aas function

  2. Generation of conditional aas mutants to confirm essentiality

  3. Medicinal chemistry optimization of hit compounds

  4. Cell penetration studies for potential inhibitors

  5. Cytotoxicity testing against mammalian cell lines

  6. Animal model studies for promising candidates

• What is the role of Salmonella paratyphi B Bifunctional protein aas in antimicrobial resistance, and how can this be experimentally investigated?

  While direct evidence for aas involvement in antimicrobial resistance is not established in the provided resources, methodological approaches to investigate potential connections include:

  Table 8: Experimental Approaches to Investigate aas in Antimicrobial Resistance

  Approach	Description	Expected Outcome
  Gene knockout studies	Generate aas deletion mutants in resistant strains	Determine if loss of aas affects resistance profiles
  Overexpression analysis	Express aas at elevated levels in susceptible strains	Test if overexpression confers increased resistance
  Comparative genomics	Compare aas sequences between resistant and susceptible isolates	Identify potential resistance-associated mutations
  Transcriptional response	Measure aas expression levels after antibiotic exposure	Determine if aas is part of stress response to antibiotics
  Protein-antibiotic interaction	Test direct binding between purified aas and antibiotics	Identify if aas directly interacts with antibiotics

  Knowledge of multidrug resistance in Salmonella Paratyphi B lineages provides context: certain clones carry resistance-encoding genomic elements including Salmonella genomic island 1 (SGI-1) and class 2 integrons with multiple resistance genes . These genetic elements are particularly prevalent in the O:5 antigen negative lineage that dominates in poultry across Western Europe .

• How can researchers design and implement protein-protein interaction studies to identify aas binding partners in Salmonella pathogenesis?

  Identifying protein-protein interactions involving aas requires a multi-technique approach:

  Table 9: Protein-Protein Interaction Methodologies for aas Research

  Technique	Experimental Design	Advantage	Limitation
  Co-immunoprecipitation	Pull-down with anti-His antibodies from bacterial lysates expressing His-tagged aas	Preserves native conditions	May miss transient interactions
  Bacterial two-hybrid	Construct fusion proteins with aas and potential partners linked to reporter components	In vivo detection in bacterial context	False positives from non-specific interactions
  Proximity labeling	Express aas fused to BioID or APEX2 in Salmonella	Captures transient interactions in native environment	Requires genetic modification of bacteria
  Crosslinking mass spectrometry	Chemical crosslinking of protein complexes followed by MS identification	Maps interaction interfaces at amino acid resolution	Complex data analysis
  Surface plasmon resonance	Immobilize purified aas on sensor chip, flow potential partners	Provides binding kinetics and affinity constants	Requires purified potential partners

  For investigating aas interactions in the context of virulence, researchers should focus on potential interactions with:

  1. Components of Salmonella pathogenicity islands (SPIs)

  2. Type III secretion system (TTSS) proteins

  3. Regulatory proteins controlling virulence gene expression

  4. Host cell proteins during infection

  5. Components of antimicrobial resistance mechanisms

• What are the evolutionary implications of comparative genomic analysis of aas across Salmonella paratyphi B lineages and other Salmonella serotypes?

  Comparative genomics approaches offer insights into the evolutionary history and functional specialization of aas:

  Table 10: Comparative Genomics Approaches for Evolutionary Analysis of aas

  Analysis Type	Methodology	Evolutionary Insight
  Sequence conservation	Multiple sequence alignment across Salmonella serotypes	Identify universally conserved vs. lineage-specific regions
  Selection pressure analysis	Calculate dN/dS ratios across coding sequence	Detect regions under positive or purifying selection
  Recombination detection	Use algorithms like Gubbins to identify recombination events	Determine if aas has undergone horizontal gene transfer
  Gene neighborhood analysis	Compare genomic context of aas across lineages	Identify operon structure conservation or reorganization
  Protein domain architecture	Compare domain organization across serotypes	Detect domain shuffling or acquisition events

  The existence of distinct lineages within Salmonella Paratyphi B with varying virulence profiles suggests potential functional diversification of proteins like aas. Particularly interesting would be comparisons between:

  1. The O:5 positive and O:5 negative lineages of Paratyphi B, which differ in virulence gene repertoires

  2. d-Tartrate fermenting (dT+) and non-fermenting variants, associated with different disease presentations

  3. PG1 lineage strongly associated with invasive disease versus other phylogenetic groups

  4. Paratyphi B lineages and other Salmonella serotypes to understand serotype-specific adaptations

• How can functional genomics approaches be employed to understand the role of aas in Salmonella paratyphi B physiology and pathogenesis?

  Functional genomics offers comprehensive approaches to understand aas function:

  Table 11: Functional Genomics Strategies for aas Characterization

  Approach	Experimental Design	Expected Outcome
  Transcriptomics (RNA-Seq)	Compare gene expression profiles between wild-type and aas mutants	Identify regulatory networks involving aas
  Transposon sequencing (Tn-Seq)	Create transposon library in aas mutant background and compare to wild-type	Identify synthetic lethal interactions
  Proteomics	Compare protein abundance in wild-type versus aas mutants	Identify post-transcriptional effects of aas deletion
  Metabolomics	Profile metabolite changes in aas mutants	Connect aas function to specific metabolic pathways
  CRISPR interference	Create CRISPRi library targeting genes in aas mutant background	Identify genetic interactions with aas

  Implementation strategies should include:

  1. Creating precise deletion or conditional mutants of aas

  2. Testing mutant phenotypes under various stress conditions

  3. Performing infection models with mutants

  4. Complementation studies to confirm phenotypes

  5. Integration of multi-omics data using systems biology approaches

  This approach is particularly relevant given the distinct disease phenotypes associated with different Salmonella Paratyphi B lineages, ranging from serious systemic infections to self-limiting gastroenteritis .

• What methodologies are most effective for studying the potential role of aas in biofilm formation and persistence in Salmonella paratyphi B?

  Biofilm formation is critical for bacterial persistence and antimicrobial resistance:

  Table 12: Methodologies for Studying aas in Biofilm Biology

  Methodology	Experimental Design	Measurement Parameter
  Crystal violet assay	Compare biofilm formation between wild-type and aas mutants in microplates	Quantitative biofilm biomass
  Confocal laser scanning microscopy	Fluorescently tag wild-type and mutant bacteria, visualize biofilm architecture	3D structure, thickness, bacterial distribution
  Flow cell systems	Grow biofilms under continuous flow conditions with wild-type and mutants	Dynamic formation, maturation, and dispersal
  Transcriptomics of biofilm cells	Extract RNA from biofilm vs. planktonic cells, compare aas expression	Differential gene expression in biofilm state
  Mixed-species biofilms	Co-culture with relevant environmental or host microbiota	Ecological interactions within biofilms

  Considering that certain Salmonella Paratyphi B lineages show persistence in specific environments, such as poultry production facilities in Western Europe , understanding aas contributions to biofilm formation could provide insights into:

  1. Environmental persistence mechanisms

  2. Resistance to disinfectants and antibiotics

  3. Host colonization strategies

  4. Survival on food processing surfaces

  5. Chronic infection establishment

• How can researchers develop high-throughput screening assays to identify modulators of aas activity for potential therapeutic applications?

  Developing effective screening assays requires clear understanding of aas function:

  Table 13: High-Throughput Screening Assay Development for aas Modulators

  Assay Type	Design Principle	Readout	Advantages
  Enzymatic activity	Substrate conversion assay based on predicted bifunctional activities	Fluorescence, absorbance, or luminescence	Direct functional measurement
  Thermal shift	Measure protein stability changes upon compound binding	Fluorescence from dye binding to hydrophobic regions	No knowledge of substrate required
  Surface plasmon resonance	Immobilized aas exposed to compound libraries	Binding kinetics and affinity	Detailed binding information
  Cell-based reporter	Engineer bacteria with reporter linked to aas-dependent pathways	Fluorescence or luminescence	Tests compounds in cellular context
  Growth inhibition	Test compound effects on wild-type vs. aas overexpressing strains	Optical density measurements	Direct antimicrobial potential

  Implementation considerations include:

  1. Assay miniaturization to 384 or 1536-well format

  2. Validation with known modulators (if available)

  3. Optimization of signal-to-background ratio

  4. Development of counter-screens for false positives

  5. Secondary assays to confirm hits and determine mechanism of action

  Given the bifunctional nature of the protein, researchers should consider developing dual-readout assays that can distinguish effects on each function separately, providing insights into function-specific modulators with potential therapeutic applications.